Trevi Therapeutics Inc. (TRVI) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-17
6:24 pm
Purchase
2025-09-3013GTrevi Therapeutics, Inc.
TRVI
BlackRock Inc.
BLK
6,804,338
5.600%
6,804,338increase
(New Position)
Filing
History
2025-08-14
5:35 pm
Sale
2025-06-3013GTrevi Therapeutics, Inc.
TRVI
VIKING GLOBAL INVESTORS LP7,505,694
5.900%
-1,684,792decrease
(-18.33%)
Filing
History
2025-08-11
6:56 pm
Unchanged
2025-08-0713DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.15,074,080
12.000%
0
(Unchanged)
Filing
History
2025-07-09
4:06 pm
Purchase
2025-06-3013GTrevi Therapeutics, Inc.
TRVI
Rubric Capital Management LP8,531,860
7.120%
4,326,731increase
(+102.89%)
Filing
History
2025-05-15
4:34 pm
Purchase
2025-03-3113GTrevi Therapeutics, Inc.
TRVI
VIKING GLOBAL INVESTORS LP9,190,486
8.700%
2,591,424increase
(+39.27%)
Filing
History
2025-05-15
09:55 am
Sale
2025-03-3113GTrevi Therapeutics, Inc.
TRVI
Frazier Life Sciences Public Fund, L.P.10,259,409
10.600%
-405,365decrease
(-3.80%)
Filing
History
2025-03-20
7:55 pm
Unchanged
2025-03-1813DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.15,074,080
15.000%
0
(Unchanged)
Filing
History
2025-02-14
6:04 pm
Sale
2024-12-3113GTrevi Therapeutics, Inc.
TRVI
Venrock Healthcare Capital Partners II, L.P.1,266,457
1.400%
-6,410,477decrease
(-83.50%)
Filing
History
2025-02-14
11:21 am
Purchase
2024-12-3113GTrevi Therapeutics, Inc.
TRVI
Frazier Life Sciences Public Fund, L.P.10,664,774
11.900%
3,283,684increase
(+44.49%)
Filing
History
2025-02-13
4:01 pm
Sale
2024-12-3113GTrevi Therapeutics, Inc.
TRVI
Rubric Capital Management LP4,205,129
4.710%
-821,802decrease
(-16.35%)
Filing
History
2025-02-13
1:41 pm
Purchase
2025-02-1313GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors Inc.1,062,500
1.200%
312,500increase
(+41.67%)
Filing
History
2024-11-14
5:51 pm
Purchase
2024-09-3013GTrevi Therapeutics, Inc.
TRVI
Venrock Healthcare Capital Partners II, L.P.7,676,934
9.990%
969,370increase
(+14.45%)
Filing
History
2024-11-13
4:30 pm
Sale
2024-09-3013GTrevi Therapeutics, Inc.
TRVI
Rubric Capital Management LP5,026,931
6.920%
-657,489decrease
(-11.57%)
Filing
History
2024-11-08
6:57 pm
Unchanged
2024-11-0613DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.15,074,080
18.700%
0
(Unchanged)
Filing
History
2024-11-06
10:30 am
Purchase
2024-09-3013GTrevi Therapeutics, Inc.
TRVI
Frazier Life Sciences Public Fund, L.P.7,381,090
10.200%
717,500increase
(+10.77%)
Filing
History
2024-10-23
2:44 pm
Sale
2024-09-3013GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors Inc.750,000
1.030%
-641,577decrease
(-46.10%)
Filing
History
2024-07-11
5:52 pm
Purchase
2024-06-2813GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors Inc.1,391,577
1.980%
465,561increase
(+50.28%)
Filing
History
2024-07-10
4:16 pm
Sale
2022-05-1213GTrevi Therapeutics, Inc.
TRVI
MAI Capital Management1,519,650
2.200%
-21,821decrease
(-1.42%)
Filing
History
2024-05-21
6:34 pm
Purchase
2024-05-0713DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.15,074,080
20.300%
703,704increase
(+4.90%)
Filing
History
2024-04-25
7:39 pm
Sale
2024-03-3113GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors Inc.926,016
1.340%
-1,573,977decrease
(-62.96%)
Filing
History
Goto 0, 1, 2, Next